Charlene Stern, J.D., Ph.D. was part of the team that launched Editas Medicine in 2013. As Head of Legal, she oversees and manages all legal matters, including corporate governance, securities compliance and SEC reporting, partnering and licensing transactions, financings, and intellectual property strategy. She also serves as Editas Medicine’s Corporate Secretary. Prior to Editas Medicine, Charlene was senior patent counsel at AVEO Oncology, where she was responsible for developing and executing AVEO’s intellectual property strategy. Earlier in her career, she was a senior attorney in the Boston office of Goodwin LLP and a patent agent at Foley Hoag LLP. Before beginning her legal career, Charlene was an American Cancer Society post-doctoral fellow at Dana-Farber Cancer Institute. She received her J.D. from Suffolk University Law School, a Ph.D. in cell and molecular biology from Yale University, and an A.B. in biochemistry from Mount Holyoke College.